Immunoglobulin treatment for B-cell immunodeficiencies

被引:2
|
作者
Freeman, Catherine M. [1 ]
Squire, Jacqueline D. [2 ]
Joshi, Avni Y. [3 ,4 ]
机构
[1] Mayo Clin, Div Allergy, Asthma & Clin Immunol, Scottsdale, AZ USA
[2] Mayo Clin, Dept Med, Div Pulm, Allergy, Jacksonville, FL USA
[3] Mayo Clin, Div Pediat & Adult Allergy & Immunol, Rochester, MN USA
[4] Mayo Clin Childrens Ctr, 200 First St SW, Rochester, MN 55905 USA
关键词
IVIG; Vaccine; Immunodeficiency; Immunoglobulin; SUBCUTANEOUS IMMUNOGLOBULIN; INTRAVENOUS IMMUNOGLOBULIN; THERAPY; MANAGEMENT; GLOBULIN; DISEASE;
D O I
10.1016/j.jim.2022.113336
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This article aims to describe the rationale and utility of immunoglobulin therapies in patients with B-cell im-munodeficiency states. We describe the historical perspective, mechanism of actions, and indications for use in this population. We then focus upon management pearls and special considerations for its utility. Finally, we elaborate upon the important economic implications for these patients and the need to develop individualized management strategies in this vulnerable population.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Cost-Effectiveness of Intravenous Immunoglobulin (IVIG) Treatment in Patients with B-Cell Immunodeficiencies
    Smirnova, I. N.
    Kosacheva, T. G.
    Kuzmenko, N. B.
    Shcherbina, A.
    Novichkova, G. A.
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S301 - S301
  • [2] Primary B-cell immunodeficiencies
    Smith, Tukisa
    Cunningham-Rundles, Charlotte
    [J]. HUMAN IMMUNOLOGY, 2019, 80 (06) : 351 - 362
  • [3] Primary immunodeficiencies and B-cell lymphomas
    Anunciacion Martin-Mateos, Maria
    Piquer Gibert, Monica
    [J]. BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2016, 73 (01): : 18 - 25
  • [4] TERMINAL B-CELL MATURATION AND IMMUNOGLOBULIN-SYNTHESIS INVITRO IN PATIENTS WITH PRIMARY AND SECONDARY IMMUNODEFICIENCIES
    VONBISMARCK, U
    PEEST, D
    DRAGER, R
    SERBIN, A
    SCHLESIER, M
    PETER, HH
    [J]. IMMUNITAT UND INFEKTION, 1984, 12 (02): : 75 - 87
  • [5] Modern management of primary B-cell immunodeficiencies
    Hoernes, Miriam
    Seger, Reinhard
    Reichenbach, Janine
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2011, 22 (08) : 758 - 769
  • [6] Flow cytometry for B-cell subset analysis in immunodeficiencies
    Kum, Attila
    Akha, Amir A. Sadighi
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2022, 509
  • [7] Successful treatment of autoimmune and lymphoproliferative complications of patients with intrinsic B-cell immunodeficiencies with Rituximab
    Hennig, Christian
    Baumann, Ulrich
    Ilginus, Claudia
    Horneff, Gerd
    Foell, Juergen
    Hansen, Gesine
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (03) : 445 - 448
  • [8] CHEMICAL CHARACTERIZATION OF B-CELL IMMUNOGLOBULIN
    LIFTER, J
    CHOI, YS
    [J]. FEDERATION PROCEEDINGS, 1978, 37 (06) : 1838 - 1838
  • [9] B-CELL AND IMMUNOGLOBULIN IMMUNODEFICIENCY IN THE ELDERLY
    RICHMOND, GW
    ZEITZ, HJ
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1993, 13 (03) : 517 - 533
  • [10] IMMUNOGLOBULIN TRANSPORT IN B-CELL DEVELOPMENT
    PILLAI, S
    [J]. INTERNATIONAL REVIEW OF CYTOLOGY-A SURVEY OF CELL BIOLOGY, 1991, 130 : 1 - 36